معرفی
Dr. Armen Parsyan is a Canadian and American board-certified Clinician-Scientist and Assistant Professor at the Schulich School of Medicine & Dentistry (Western University). He holds joint appointments in the Department of Surgery, Oncology and Anatomy and Cell Biology, emphasizing translational breast cancer research.
- Education: PhD (University of Cambridge), MPH (Boston University), MD (unspecified), postdoctoral training at McGill University and Princess Margaret Cancer Centre.
- Research Focus: Dr. Parsyan investigates triple-negative breast cancer using patient-derived organoids, spatial omics, and CRISPR-Cas9 to study drug/radiotherapy resistance mechanisms, immune system interactions, and metastasis.
Article Trends: His publications span DNA repair proteins (Artemis/DCLRE1C), radiosensitization, PLK4/AURKB inhibition, and clinical trial methodologies. Recent work (2025) highlights Artemis as a radiosensitivity target, while earlier studies (2024) explore PLK4 and AURKB in radiotherapy enhancement.
Collaborations: Affiliated with the Breast Cancer Canada Translational Research Unit at Verspeeten Family Cancer Centre. Leads a multidisciplinary team including clinical residents, postdoctoral fellows, and students.
